Spyre Therapeutics, Inc. (SYRE)

106.65 +0.16 (+0.15%) USD  |  NASDAQ  |  Aug 24, 16:00
107.01 +0.36 (+0.34%) After-Hours: 07:35
More

Spyre Therapeutics EV to EBITDA

EV to EBITDA Chart

View EV to EBITDA for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to EBITDA Chart
Start Trial

Historical EV to EBITDA Data

View and export this data back to . Start Trial.
Date Value

EV to EBITDA Definition

The EV to EBITDA measures the ratio between enterprise value and earnings before interest, taxes, depreciation, and amortization. This metric is important to analyze when looking at a company's true value based on how much they are valued at compared to how money they are earning.

Read full definition.

EV to EBITDA Range, Past 5 Years

View EV to EBITDA Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to EBITDA Benchmarks

View EV to EBITDA Benchmarks
Start Trial
AbbVie, Inc. Upgrade
vTv Therapeutics, Inc. --
BridgeBio Pharma, Inc. --
Praxis Precision Medicines, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade

EV to EBITDA Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade